4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-22-038446
Director acquired 12,006 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chrousos Phaedra Director | 2022-06-16 | Grant or award | +12,006 | 24,931 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chrousos Phaedra Director | 2022-06-16 | Grant or award · Stock Option (Right to Buy) | +24,707 | 24,707 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…